These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
317 related articles for article (PubMed ID: 17302605)
1. Phosphoinositide 3-kinase is not overexpressed in melanocytic lesions. Singh RS; Diwan AH; Zhang PS; Prieto VG J Cutan Pathol; 2007 Mar; 34(3):220-5. PubMed ID: 17302605 [TBL] [Abstract][Full Text] [Related]
2. Different patterns of expression of the erbB family of receptor tyrosine kinases in common nevi, dysplastic nevi, and primary malignant melanomas: an immunohistochemical study. Feinmesser M; Veltman V; Morgenstern S; Tobar A; Gutman H; Kaganovsky E; Tzabari C; Sulkes J; Okon E Am J Dermatopathol; 2010 Oct; 32(7):665-75. PubMed ID: 20559114 [TBL] [Abstract][Full Text] [Related]
3. Expression of insulin-like growth factor-binding protein 2 in melanocytic lesions. Wang H; Shen SS; Wang H; Diwan AH; Zhang W; Fuller GN; Prieto VG J Cutan Pathol; 2003 Nov; 30(10):599-605. PubMed ID: 14744083 [TBL] [Abstract][Full Text] [Related]
4. Loss of expression of protein kinase a regulatory subunit 1alpha in pigmented epithelioid melanocytoma but not in melanoma or other melanocytic lesions. Zembowicz A; Knoepp SM; Bei T; Stergiopoulos S; Eng C; Mihm MC; Stratakis CA Am J Surg Pathol; 2007 Nov; 31(11):1764-75. PubMed ID: 18059235 [TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical expression patterns of the microRNA-processing enzyme Dicer in cutaneous malignant melanomas, benign melanocytic nevi and dysplastic melanocytic nevi. Sand M; Gambichler T; Sand D; Altmeyer P; Stuecker M; Bechara FG Eur J Dermatol; 2011; 21(1):18-21. PubMed ID: 21262599 [TBL] [Abstract][Full Text] [Related]
6. hTERT expression in melanocytic lesions: an immunohistochemical study on paraffin-embedded tissue. Fullen DR; Zhu W; Thomas D; Su LD J Cutan Pathol; 2005 Nov; 32(10):680-4. PubMed ID: 16293180 [TBL] [Abstract][Full Text] [Related]
7. Mast cells in melanocytic skin lesions. An immunohistochemical and quantitative study. Dyduch G; Okoń K; Pescarini E Pol J Pathol; 2011 Sep; 62(3):139-44. PubMed ID: 22102069 [TBL] [Abstract][Full Text] [Related]
8. Minichromosome maintenance protein expression in benign nevi, dysplastic nevi, melanoma, and cutaneous melanoma metastases. Boyd AS; Shakhtour B; Shyr Y J Am Acad Dermatol; 2008 May; 58(5):750-4. PubMed ID: 18249467 [TBL] [Abstract][Full Text] [Related]
9. Expression of Phosphatase and Tensin Homologue, phospho-Akt, and p53 in Acral Benign and Malignant Melanocytic Neoplasms (Benign Nevi, Dysplastic Nevi, and Acral Melanomas). Lyu SM; Wu JY; Byun JY; Choi HY; Park SH; Choi YW Ann Dermatol; 2016 Oct; 28(5):548-554. PubMed ID: 27746632 [TBL] [Abstract][Full Text] [Related]
10. Fascin expression in melanocytic lesions of the skin. YILDIZ L; KEFELI M; AYDIN O; KANDEMIR B Eur J Dermatol; 2009; 19(5):445-50. PubMed ID: 19527987 [TBL] [Abstract][Full Text] [Related]
11. Diagnostic utility of combining PRAME and HMB-45 stains in primary melanocytic tumors. Rasic D; Korsgaard N; Marcussen N; Precht Jensen EM Ann Diagn Pathol; 2023 Dec; 67():152211. PubMed ID: 37717457 [TBL] [Abstract][Full Text] [Related]
12. Inducible nitric oxide synthase expression in benign and malignant cutaneous melanocytic lesions. Massi D; Franchi A; Sardi I; Magnelli L; Paglierani M; Borgognoni L; Maria Reali U; Santucci M J Pathol; 2001 Jun; 194(2):194-200. PubMed ID: 11400148 [TBL] [Abstract][Full Text] [Related]
13. Beclin 1 and LC3 autophagic gene expression in cutaneous melanocytic lesions. Miracco C; Cevenini G; Franchi A; Luzi P; Cosci E; Mourmouras V; Monciatti I; Mannucci S; Biagioli M; Toscano M; Moretti D; Lio R; Massi D Hum Pathol; 2010 Apr; 41(4):503-12. PubMed ID: 20004946 [TBL] [Abstract][Full Text] [Related]
14. IMP-3 EXPRESSION IN BENIGN MELANOCYTIC NEVI, DYSPLASTIC NEVI AND MALIGNANT MELANOMA: PRELIMINARY FINDINGS IN BULGARIAN PATIENTS. Chokoeva AA; Ananiev J; Wollina U; Tana C; Lotti T; Cardoso JC; Tchernev G J Biol Regul Homeost Agents; 2015; 29(3):695-9. PubMed ID: 26403409 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of telomerase activity in cutaneous melanocytic proliferations. Miracco C; Pacenti L; Santopietro R; Laurini L; Biagioli M; Luzi P Hum Pathol; 2000 Sep; 31(9):1018-21. PubMed ID: 11014565 [TBL] [Abstract][Full Text] [Related]
16. Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions. Nasr MR; El-Zammar O Am J Dermatopathol; 2008 Apr; 30(2):117-22. PubMed ID: 18360113 [TBL] [Abstract][Full Text] [Related]